655 related articles for article (PubMed ID: 18945407)
1. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
3. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening programs in Latin America and the Caribbean.
Murillo R; Almonte M; Pereira A; Ferrer E; Gamboa OA; Jerónimo J; Lazcano-Ponce E
Vaccine; 2008 Aug; 26 Suppl 11():L37-48. PubMed ID: 18945401
[TBL] [Abstract][Full Text] [Related]
5. New approaches to cervical cancer screening in Latin America and the Caribbean.
Herrero R; Ferreccio C; Salmerón J; Almonte M; Sánchez GI; Lazcano-Ponce E; Jerónimo J
Vaccine; 2008 Aug; 26 Suppl 11():L49-58. PubMed ID: 18945402
[TBL] [Abstract][Full Text] [Related]
6. A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean.
Luciani S; Andrus JK
Reprod Health Matters; 2008 Nov; 16(32):59-66. PubMed ID: 19027623
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
Andrus JK; Lewis MJ; Goldie SJ; García PJ; Winkler JL; Ruiz-Matus C; de Quadros CA
Vaccine; 2008 Aug; 26 Suppl 11():L80-7. PubMed ID: 18945405
[TBL] [Abstract][Full Text] [Related]
8. Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean.
Winkler JL; Wittet S; Bartolini RM; Creed-Kanashiro HM; Lazcano-Ponce E; Lewis-Bell K; Lewis MJ; Penny ME
Vaccine; 2008 Aug; 26 Suppl 11():L73-9. PubMed ID: 18945404
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
[TBL] [Abstract][Full Text] [Related]
10. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
12. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean.
Almonte M; Albero G; Molano M; Carcamo C; García PJ; Pérez G
Vaccine; 2008 Aug; 26 Suppl 11():L16-36. PubMed ID: 18945400
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
[TBL] [Abstract][Full Text] [Related]
15. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
Shi JF; Qiao YL; Smith JS; Dondog B; Bao YP; Dai M; Clifford GM; Franceschi S
Vaccine; 2008 Aug; 26 Suppl 12():M53-9. PubMed ID: 18945414
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
Saslow D; Wheeler CM
Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
[TBL] [Abstract][Full Text] [Related]
18. Vaccination against HPV: indications for women and the impact on the cervical screening programme.
Heideman DA; Snijders PJ; Berkhof J; Verheijen RH; Helmerhorst TJ; Meijer CJ
BJOG; 2008 Jul; 115(8):938-46. PubMed ID: 18651878
[TBL] [Abstract][Full Text] [Related]
19. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
Wheeler CM
Nat Clin Pract Oncol; 2007 Apr; 4(4):224-35. PubMed ID: 17392713
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
